| Literature DB >> 24016523 |
Andrzej Piatkowski1, Gerrit Grieb, David Simons, Jürgen Bernhagen, Rene R van der Hulst.
Abstract
The term endothelial progenitor cell (EPC) was established more than 10 years ago and is used to refer to a group of circulating cells that display endothelial lineage qualities and are able to home to areas of ischemia or vascular injury and to facilitate the repair of damaged blood vessels or develop new vessels as needed. This chapter reviews the current lineage relationships among all the cells called EPC and will clear the terminology used in EPC research. Furthermore, an overview of the clinical and in vitro research, as well as cytokine and drug interactions and potential EPC applications, is given.Entities:
Keywords: Cytokines; Drug interactions; Endothelial cells; Hematopoietic cells; Neovascularization; Regeneration
Mesh：
Substances：
Year: 2013 PMID： 24016523 DOI： 10.1016/B978-0-12-407694-5.00002-X
Source DB: PubMed Journal: Int Rev Cell Mol Biol ISSN： 1937-6448 Impact factor: 6.813